{"id":"https://openalex.org/W2166498909","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2539","title":"Targeting the Mitogen-Activated Protein Kinase Pathway in the Treatment of Malignant Melanoma","display_name":"Targeting the Mitogen-Activated Protein Kinase Pathway in the Treatment of Malignant Melanoma","alternate_titles":[],"publication_year":2006,"publication_date":"2006-04-01","ids":{"openalex":"https://openalex.org/W2166498909","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2539","mag":"2166498909","pmid":"https://pubmed.ncbi.nlm.nih.gov/16609061"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-05-2539","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2539","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-2539","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2166498909"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105939567","display_name":"David J. Panka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David J. Panka","raw_affiliation_strings":["Authors' Affiliation: Division of Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Division of Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052526230","display_name":"Michael B. Atkins","orcid":"https://orcid.org/0000-0003-3901-9924","observed_orcids":["https://orcid.org/0000-0003-3901-9924"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael B. Atkins","raw_affiliation_strings":["Authors' Affiliation: Division of Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Division of Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108518835","display_name":"James Walter Mier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James W. Mier","raw_affiliation_strings":["Authors' Affiliation: Division of Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Division of Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2317,"has_fulltext":false,"cited_by_count":132,"citation_normalized_percentile":{"value":0.76227163,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"12","issue":"7","first_page":"2371s","last_page":"2375s"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8309999704360962},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9369999766349792},{"id":"https://openalex.org/keywords/ras-raf-erk-signaling","display_name":"Ras/Raf/ERK signaling","score":0.8709999918937683},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.781000018119812},{"id":"https://openalex.org/keywords/nras-mutation","display_name":"NRAS mutation","score":0.9929999709129333},{"id":"https://openalex.org/keywords/mapk-inhibitors","display_name":"MAPK inhibitors","score":0.7310000061988831},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9200000166893005},{"id":"https://openalex.org/keywords/caspase-activation","display_name":"caspase activation","score":0.7620000243186951},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.9100000262260437},{"id":"https://openalex.org/keywords/endothelial-cells","display_name":"endothelial cells","score":0.8410000205039978},{"id":"https://openalex.org/keywords/hepatocyte-growth-factor","display_name":"hepatocyte growth factor","score":0.921999990940094},{"id":"https://openalex.org/keywords/fibroblast-growth-factor","display_name":"fibroblast growth factor","score":0.8849999904632568},{"id":"https://openalex.org/keywords/autocrine-growth-factor","display_name":"autocrine growth factor","score":0.8690000176429749}],"concepts":[{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.790206253528595},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6326831579208374},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.6222889423370361},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5164816379547119},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5001697540283203},{"id":"https://openalex.org/C132149769","wikidata":"https://www.wikidata.org/wiki/Q899651","display_name":"Mitogen-activated protein kinase","level":3,"score":0.4910457134246826},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.47461357712745667},{"id":"https://openalex.org/C128240485","wikidata":"https://www.wikidata.org/wiki/Q786998","display_name":"Autocrine signalling","level":3,"score":0.4388171434402466},{"id":"https://openalex.org/C99405784","wikidata":"https://www.wikidata.org/wiki/Q410434","display_name":"c-Raf","level":5,"score":0.436079740524292},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4145594835281372},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3993373513221741},{"id":"https://openalex.org/C90934575","wikidata":"https://www.wikidata.org/wiki/Q6593810","display_name":"Mitogen-activated protein kinase kinase","level":4,"score":0.37012889981269836},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10615238547325134},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07666623592376709}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D020928","descriptor_name":"Mitogen-Activated Protein Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-05-2539","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2539","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-2539","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:16609061","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16609061","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000334428","display_name":"SPORE in Skin Cancer","funder_award_id":"P50CA093683","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1509340652","https://openalex.org/W1565041471","https://openalex.org/W1966272088","https://openalex.org/W1977983659","https://openalex.org/W1985035689","https://openalex.org/W2002195822","https://openalex.org/W2005909927","https://openalex.org/W2006134426","https://openalex.org/W2007057690","https://openalex.org/W2024296098","https://openalex.org/W2041687747","https://openalex.org/W2047669024","https://openalex.org/W2047942701","https://openalex.org/W2050085273","https://openalex.org/W2068944371","https://openalex.org/W2093351885","https://openalex.org/W2093628776","https://openalex.org/W2101024186","https://openalex.org/W2103027517","https://openalex.org/W2107385057","https://openalex.org/W2121796473","https://openalex.org/W2136833729","https://openalex.org/W2140765540","https://openalex.org/W2150168131","https://openalex.org/W2150588063","https://openalex.org/W2155299791","https://openalex.org/W2163188200","https://openalex.org/W2168066027","https://openalex.org/W2329587797"],"related_works":["https://openalex.org/W1573698160","https://openalex.org/W2136833729","https://openalex.org/W1510276410","https://openalex.org/W2092286514","https://openalex.org/W1504702309","https://openalex.org/W2154382625","https://openalex.org/W110232055","https://openalex.org/W7169805443","https://openalex.org/W2977238263"],"abstract_inverted_index":{"The":[0,117],"mitogen-activated":[1],"protein":[2],"kinase":[3,108,208],"(MAPK;":[4],"i.e.,":[5],"Ras-Raf-Erk)":[6],"pathway":[7,133,151,289],"is":[8],"an":[9],"attractive":[10],"target":[11],"for":[12],"therapeutic":[13],"intervention":[14],"in":[15,22,54,59,84,111,138,158,168,182,252,280,302],"melanoma":[16,124,159,193],"due":[17],"to":[18,81,126,135,154,166,185,265,277,293],"its":[19,136],"integral":[20],"role":[21],"the":[23,31,39,46,67,90,93,112,115,128,131,139,142,145,150,169,172,190,196,216,222,235,246,256,271,282,288,297,303,306],"regulation":[24,113],"of":[25,34,69,92,95,114,119,130,141,149,171,192,198,211,219,224,234,249,259,287,299,305],"proliferation,":[26],"invasiveness,":[27],"and":[28,30,42,77,106,144,178,213,221,254,273,296],"survival":[29],"recent":[32,201],"availability":[33],"pharmaceutical":[35],"agents":[36,261],"that":[37,44,147,215,242,255],"inhibit":[38],"various":[40],"kinases":[41],"GTPases":[43],"comprise":[45],"pathway.":[47,116,237],"Genetic":[48],"studies":[49,64,202,239],"have":[50,65,88,203,240],"identified":[51,204],"activating":[52],"mutations":[53],"either":[55],"B-raf":[56],"or":[57],"N-ras":[58],"most":[60],"cutaneous":[61],"melanomas.":[62],"Other":[63,238],"delineated":[66],"contribution":[68],"autocrine":[70],"growth":[71,75,79],"factors":[72,275],"(e.g.,":[73,104],"hepatocyte":[74],"factor":[76],"fibroblast":[78],"factor)":[80],"MAPK":[82,132,161,236,278,300],"activation":[83,187,279],"melanoma.":[85],"Still,":[86],"others":[87],"emphasized":[89],"consequences":[91],"down-modulation":[94],"endogenous":[96],"raf":[97,212,220,225,250],"inhibitors,":[98],"such":[99],"as":[100],"Sprouty":[101],"family":[102,175],"members":[103,176],"SPRY2)":[105],"raf-1":[107],"inhibitory":[109],"protein,":[110],"diversity":[118],"molecular":[120],"mechanisms":[121,283],"used":[122],"by":[123,284],"cells":[125,194,244],"ensure":[127],"activity":[129],"attests":[134],"importance":[137],"evolution":[140],"disease":[143],"likelihood":[146],"inhibitors":[148,251,301],"may":[152],"prove":[153,291],"be":[155],"highly":[156],"effective":[157],"treatment.":[160],"inhibition":[162,226,286],"has":[163],"been":[164],"shown":[165],"result":[167],"dephosphorylation":[170],"proapoptotic":[173],"Bcl-2":[174],"Bad":[177],"Bim.":[179],"This":[180,268],"process":[181],"turn":[183],"leads":[184],"caspase":[186],"and,":[188],"ultimately,":[189],"demise":[191],"through":[195,229],"induction":[197],"apoptosis.":[199],"Several":[200],"non-mitogen-activated":[205],"protein/extracellular":[206],"signal-regulated":[207],"kinase-binding":[209],"partners":[210],"suggested":[214,241],"prosurvival":[217],"effects":[218],"lethality":[223],"are":[227,245,262],"mediated":[228],"these":[230,260],"alternative":[231],"targets,":[232],"independent":[233],"endothelial":[243],"primary":[247],"targets":[248],"vivo":[253],"antitumor":[257],"effect":[258],"largely":[263],"attributable":[264],"angiogenesis":[266],"inhibition.":[267],"article":[269],"reviews":[270],"genetic":[272],"biochemical":[274],"contributing":[276],"melanoma,":[281],"which":[285],"might":[290],"deleterious":[292],"tumor":[294],"cells,":[295],"potential":[298],"treatment":[304],"disease.":[307]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2166498909","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
